FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats

By sjmartinez • October 1, 2024

Larauche M, Mulak A, Ha C, Million M, Arnett S, Germano P, Pearson JP, Currie MG, Taché Y. FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF₁ agonist mediated visceral hypersensitivity in male rats. Neurogastroenterol Motil. 2024 Sep 30:e14927. doi: 10.1111/nmo.14927. Epub ahead of print. PMID: 39344695.

Tags: anandamide, cortagine, defecation, Digestive Diseases, Irritable Bowel Syndrome, Publications, rat, URB597, Veterans Administration, Visceral pain

Corrigendum to “Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models” [Environ. Res. 248 (2024) 118242]

Chang C, Gupta R, Sedighian F, Louie A, Gonzalez DM, Le C, Cho JM, Park SK, Castellanos J, Ting TW, Dong TS, Arias-Jayo N, Lagishetty[...]

Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative

Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.